Gedeon Richter

    OverviewSuggest Edit

    Gedeon Richter is engaged in research, development, manufacture, marketing, and distribution of pharmaceutical products worldwide. The Company focuses on the development of products in various therapeutic areas, including gynecological, cardiovascular, and central nervous system. It offers emergency contraceptives, hormone replacements, fungicides, preparations used for the treatment of uterine fibroids, contraceptive devices, as well as products for menopausal and pregnancy care, obstetrics and gynecological conditions. Gedeon Richter also provides central nervous system products for the treatment of chronic cerebral circulatory disorders and neuropathic pain, as well as anaesthetics, anti-anxiety medications, sleeping pills, anti-epileptic medicines, and products for the prevention and treatment of various cardiovascular diseases.

    TypePublic
    Founded1901
    HQBudapest, HU
    Websiterichter.hu
    Employee Ratings3.8

    Latest Updates

    Employees (est.) (May 2021)12,842
    Cybersecurity ratingDMore

    Gedeon Richter Office Locations

    Gedeon Richter has offices in Budapest, Yerevan, Baku, Minsk and in 22 other locations
    Yerevan, AM
    22 Ghazar Parpetsi St
    Baku, AZ
    35 Istiglaliyyat
    Minsk, BY
    505 5 praspiekt Pieramožcaŭ
    Sofia, BG
    Akad. Ivan Geshov blvd. 2E
    Kesklinn, EE
    2 A. Adamsoni
    Tbilisi, GE
    8 Simon Kandelaki St
    Show all (26)

    Gedeon Richter Online and Social Media Presence

    Embed Graph

    Gedeon Richter News and Updates

    Cariprazine significantly reduces agitation and hostility in patients with schizophrenia based on Gedeon Richter Plc's analyses

    BUDAPEST, Hungary, Sept. 15, 2020 /PRNewswire/ -- On 12-15 September 2020, during the 33thAnnual Meeting of the European College of Neuropsychopharmacology (ECNP) – which was held virtually due to the COVID-19 pandemic situation – new analyses of cariprazine studies with schizophrenia...

    Cariprazine Significantly Improved Negative Symptoms of Schizophrenia Based on Real Life Data from a New Observational Study by Gedeon Richter Plc

    BUDAPEST, Hungary, July 8, 2020 /PRNewswire/ -- On 4-7 July 2020, during the 28th Annual Meeting of the European Psychiatric Association (EPA) – which was held virtually due to the COVID-19 pandemic situation – new analysis of cariprazine studies in negative symptoms of schizophrenia was...

    Similar Response Rate but Higher Degrees of Clinical Improvement Were More Likely to Achieve With Cariprazine Compared to Risperidone - A Study by Gedeon Richter Plc

    BUDAPEST, Hungary, Sept. 11, 2019 /PRNewswire/ -- On 7-10 September 2019, during the 32th psychiatry congress of the European College of Neuropsychopharmacology Congress (ECNP) in Copenhagen new analysis of cariprazine studies were presented. According to the presentation, clinical...

    Experts from Gedeon Richter Discuss if 'Social Egg Freezing' Alleviates or Increases the Pressure Among Women to Have a Baby Early

    VIENNA, June 24, 2019 /PRNewswire/ -- Experts have gathered at a Gedeon Richter-sponsored panel discussion to debate the pressure paradox of egg freezing, a procedure which is on the rise in Europe.1 In the EU, the average age of women having their first child is estimated to be 29, which ...

    Gedeon Richter Frequently Asked Questions

    • When was Gedeon Richter founded?

      Gedeon Richter was founded in 1901.

    • How many employees does Gedeon Richter have?

      Gedeon Richter has 12,842 employees.

    • Who are Gedeon Richter competitors?

      Competitors of Gedeon Richter include ONCOtherapeutics, Adagene and Kineta.

    • Where are Gedeon Richter offices?

      Gedeon Richter has offices in Budapest, Yerevan, Baku, Minsk and in 22 other locations.

    • How many offices does Gedeon Richter have?

      Gedeon Richter has 26 offices.